IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present in the United States and is part of the OncoDNA group which works with an international network of 35 distributors. The Group also provides biomarker testing and clinical interpretation tools to guide treatment and monitoring of late stage solid tumors and accelerate the development of new cancer drugs. IntegraGen is listed on Euronext Growth in Paris (ISIN: FR0010908723 - Mnemo: ALINT - Eligible PEA-PME).
Location: France, Ile-of-France, Evry
Member count: 11-50
Total raised: $2.4M
Founded date: 2000
Investors 2
| Date | Name | Website |
| - | DSM | dsm.com |
| - | Idinvest P... | idinvest.c... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 12.07.2012 | - | $2.4M | - | - |